FloBio gets FDA breakthrough status for rapid bleeding risk diagnostic test
The Philadelphia-based FloBio has designed the precision, point-of-care test Direct Oral Anticoagulant detection test to aid emergency medical…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Oct 23
The Philadelphia-based FloBio has designed the precision, point-of-care test Direct Oral Anticoagulant detection test to aid emergency medical…
17 Oct 23
Allia IGS Pulse, the latest addition to the US-based company’s IGS portfolio, is designed to improve workflow to…
17 Oct 23
The Aptiva CTD Essential reagent can generate a throughput of up to 600 results per hour to streamline…
16 Oct 23
This is the first next-generation sequencing (NGS)-based TMB test kit approved in China with a large gene panel…
13 Oct 23
Under the partnership, both companies will expand EndoSound's ultrasound technology into the single-use endoscopy space to enhance the…
13 Oct 23
The contract is intended to assist medical professionals in identifying and treating traumatic injuries as well as improve…
13 Oct 23
Metabolon’s newest panels help academic and commercial researchers reveal complex biological insights about liver fibrosis and kidney dysfunction
12 Oct 23
Labcorp is offering the new blood-based Amyloid-Tau-Neurodegeneration (ATN) profile test through physicians for use with patients being evaluated…
12 Oct 23
The company's continuous focus on immune, biochemical, and molecular diagnosis, as well as point-of-care testing (POCT) further highlights…
11 Oct 23
Stone Diagnostics' combination of scaled operational excellence and leading digital capabilities leveraging MyHealthAI is ideal and vital to…